Skip to main content
NIH funding notice RFA-CA-28-004

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Open. Closes February 11, 2027.

Posted
October 15, 2026
Close date
February 11, 2027
Activity codes
U24
Institutes taking part
NCI

The notices it replaced

3 notices since 2014, oldest first, each with its awards since FY2014.

  1. Posted 2014RFA-CA-14-5015 awards
  2. Posted 2019RFA-CA-20-0025 awards
  3. Posted 2019RFA-CA-20-0031 award
  4. Posted 2026RFA-CA-28-004This notice, open

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
11
6 new, 5 renewals
Median first-year cost
$2,532,382
$30,597,430 in all
Institutions
4
5 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. RESEARCH INST NATIONWIDE CHILDREN'S HOSP5
  2. ECOG-ACRIN MEDICAL RESEARCH FOUNDATION2
  3. NRG ONCOLOGY FOUNDATION, INC.2
  4. WASHINGTON UNIVERSITY2

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 SRB-5 (M2))6
  2. Special Emphasis Panel (ZCA1 GRB-S (J2))5
11 awards under RFA-CA-28-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020COG Biospecimen Bank to Support NCI NCTN (U24)2U24CA196173-06 · under RFA-CA-20-002Loh, Mignon Lee-CheunRamirez Milan, Nilsa Del CarmenSkapek, Stephen XRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $4,613,436Study section ZCA1
FY2020NRG Oncology Biospecimen Bank2U24CA196067-06 · under RFA-CA-20-002Jordan, Richard CLucas, Peter CRamirez Milan, Nilsa Del CarmenNRG ONCOLOGY FOUNDATION, INC., PAFirst-year cost $2,541,085Study section ZCA1
FY2020(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank1U24CA254445-01 · under RFA-CA-20-003Nicol, KathleenRamirez Milan, Nilsa Del CarmenRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $2,532,382Study section ZCA1
FY2020ECOG-ACRIN Biospecimen Bank to Support NCTN2U24CA196172-06 · under RFA-CA-20-002Hamilton, Stanley R.Wistuba, Ignacio I.ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, PAFirst-year cost $2,515,975Study section ZCA1
FY2020The Alliance NCTN Biorepository and Biospecimen Resource2U24CA196171-06 · under RFA-CA-20-002Cicek, MineFrankel, WendyRichards, William GWatson, Mark A.WASHINGTON UNIVERSITY, MOFirst-year cost $2,321,116Study section ZCA1
FY2020SWOG Biospecimen Bank to Support NCI NCTN2U24CA196175-06 · under RFA-CA-20-002Rae, James MichaelRamirez Milan, Nilsa Del CarmenRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $2,048,483Study section ZCA1
FY2015THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE1U24CA196171-01 · under RFA-CA-14-501Caligiuri, Michael ACicek, MineFrankel, WendyRichards, William GWatson, Mark A.WASHINGTON UNIVERSITY, MOFirst-year cost $3,327,369Study section ZCA1
FY2015SWOG Biospecimen Bank1U24CA196175-01 · under RFA-CA-14-501Gastier-Foster, Julie MRae, James MichaelRamirez Milan, Nilsa Del CarmenRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $3,211,645Study section ZCA1
FY2015COG Biospecimen Bank1U24CA196173-01 · under RFA-CA-14-501Gastier-Foster, Julie MRamirez Milan, Nilsa Del CarmenRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $2,908,438Study section ZCA1
FY2015NRG Oncology Biospecimen Bank1U24CA196067-01 · under RFA-CA-14-501Jordan, Richard CPaik, SoonmyungRamirez Milan, Nilsa Del CarmenNRG ONCOLOGY FOUNDATION, INC., PAFirst-year cost $2,292,426Study section ZCA1
FY2015ECOG-ACRIN Biorepositories to Support NCTN1U24CA196172-01 · under RFA-CA-14-501Hamilton, Stanley R.Wistuba, Ignacio I.ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, PAFirst-year cost $2,285,075Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 6 funded projects.

  1. US 11,028,448 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF IDENTIFYING RISK OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PATHWAY INHIBITOR-INDUCED HYPERTENSIONGranted June 8, 2021 to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL and Duke UniversityU24CA196171 · WASHINGTON UNIVERSITY, MO

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.